ATE316139T1 - Attenuierte pferdeherpesvirus - Google Patents

Attenuierte pferdeherpesvirus

Info

Publication number
ATE316139T1
ATE316139T1 AT99944307T AT99944307T ATE316139T1 AT E316139 T1 ATE316139 T1 AT E316139T1 AT 99944307 T AT99944307 T AT 99944307T AT 99944307 T AT99944307 T AT 99944307T AT E316139 T1 ATE316139 T1 AT E316139T1
Authority
AT
Austria
Prior art keywords
ehv
mutants
relates
vectors
equinoherpesvirus
Prior art date
Application number
AT99944307T
Other languages
English (en)
Inventor
Paulus Jacobus An Sondermeijer
Nicolaas Visser
Cherida Rachel Dhore
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE316139T1 publication Critical patent/ATE316139T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16411—Rhadinovirus, e.g. human herpesvirus 8
    • C12N2710/16461—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99944307T 1998-07-31 1999-07-26 Attenuierte pferdeherpesvirus ATE316139T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98202594 1998-07-31

Publications (1)

Publication Number Publication Date
ATE316139T1 true ATE316139T1 (de) 2006-02-15

Family

ID=8234001

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944307T ATE316139T1 (de) 1998-07-31 1999-07-26 Attenuierte pferdeherpesvirus

Country Status (9)

Country Link
US (1) US7060282B1 (de)
EP (1) EP1100925B1 (de)
AT (1) ATE316139T1 (de)
AU (1) AU758604B2 (de)
BR (1) BR9912626B1 (de)
CA (1) CA2337965C (de)
DE (1) DE69929530T2 (de)
HU (1) HUP0102861A3 (de)
WO (1) WO2000008165A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (de) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh GM-negative EHV Mutanten
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
AR040601A1 (es) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos
BRPI0417762A8 (pt) 2003-12-19 2015-12-22 Seattle Biomedical Res Institute Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina
US7722860B2 (en) 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
EA201000829A1 (ru) * 2007-12-21 2011-06-30 Глаксосмитклайн Байолоджикалс С.А. Вакцина
CA2732035A1 (en) 2008-07-30 2010-02-04 University Of Kentucky Research Foundation Equine disease model for herpesvirus neurologic disease and uses thereof
HUE033739T2 (en) * 2010-10-18 2018-01-29 Intervet Int Bv Turkey herpesvirus vector vaccine against avian influenza in poultry
TW201823465A (zh) * 2016-09-20 2018-07-01 德商百靈佳殷格翰維美迪加股份有限公司 新穎豬流感疫苗
CN109715204B (zh) * 2016-09-20 2023-08-22 勃林格殷格翰动物保健有限公司 新的ehv插入位点orf70
HUE064133T2 (hu) 2016-09-20 2024-03-28 Boehringer Ingelheim Vetmedica Gmbh Kutya adenovírus vektor
CN109790550B (zh) 2016-09-20 2024-02-09 勃林格殷格翰动物保健有限公司 新颖的启动子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014951D0 (en) 1990-07-06 1990-08-29 Univ Glasgow Equine herpesvirus-4 tk vaccine
GB9415319D0 (en) * 1994-07-29 1994-09-21 Medical Res Council HSV viral vector

Also Published As

Publication number Publication date
WO2000008165A1 (en) 2000-02-17
DE69929530T2 (de) 2006-07-20
HUP0102861A3 (en) 2005-03-29
HUP0102861A2 (hu) 2001-11-28
AU5729399A (en) 2000-02-28
BR9912626A (pt) 2001-04-24
EP1100925A1 (de) 2001-05-23
DE69929530D1 (de) 2006-04-06
CA2337965A1 (en) 2000-02-17
US7060282B1 (en) 2006-06-13
CA2337965C (en) 2009-12-15
EP1100925B1 (de) 2006-01-18
AU758604B2 (en) 2003-03-27
BR9912626B1 (pt) 2010-09-08

Similar Documents

Publication Publication Date Title
MX9700833A (es) Virus de herpes recombinante de pavo y usos del mismo.
ATE316139T1 (de) Attenuierte pferdeherpesvirus
DK0707071T3 (da) Rekombinante vektorer afledt fra adenovirus til anvendelse i genterapi
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
ES2168258T3 (es) Vectores virales recombinantes que codifican para proteinas de papilomavirus humano.
MY117686A (en) Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
AU6489986A (en) Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
WO2003046506A3 (en) Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
DK0507179T3 (da) Equine herpesvira (EHV), der indeholder fremmed
WO1999053047A3 (en) Porcine adenovirus type 3 genome
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
EP0326127A3 (de) Infektiöse Rinder-Rhinotracheitis-Virus-Insertionsmutanten, sie enthaltende Impfstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung
BR9909173A (pt) ácido nucleico, mutante de deleção de um alfa-vìrus, adenovìrus recombinante, vìrus vacìnia recombinante, plasmìdeo, vacina, e, processo para produzir uma imune resposta protetora a um alfa-vìrus
GB9818133D0 (en) Vaccine
ATE244308T1 (de) Rekombitante, equine herpesviren
AP2000001892A0 (en) Self-replicating vector for DNA immunization against HIV.
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
ES2367245T8 (es) Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo.
HUP9904201A1 (hu) Génterápiában használható, egy exogén nukleinsavat genomjában beépítve tartalmazó rekombináns vírus és egy nem virális és nem plazmid transzfektáló szer kombinációját tartalmazó transzfektáló készítmény
EP1415665A3 (de) BHV5 Mutanten
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
TW371671B (en) GE gene of a native swine pseudorabies virus and the glycoprotein thereof, their preparation and uses
WO2002078621A3 (en) Replication-competent recombinant virus and methods of use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties